CORRECTION – FDA Submission to Change the Primary Endpoint into an Industry First and Robust Clinical Measure for Superiority of CIN Phase 3 Study
NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by BeyondSpring […]